BVVA Annual Conference: Will there soon be a solution for batch transmission?



BVVA chairwoman Heike Gnekow (archive photo) reviewed the past year in terms of professional politics. / © 2022 Fräuein Fotochrom | Julia Koplin
A topic that has long been a concern for the Federal Association of Pharmacists (BVVA) is the transfer of e-prescriptions for blister packs. For the affected home care providers Pharmacies are subject to a transitional solution that expires at the end of June. Pharmacies that blister pack individually for each patient may temporarily enter the term "STELLEN" (places) in the e-dispensing data record when submitting e-prescriptions instead of the batch number. The reason: It is currently technically impossible to document the batch designations of all packaging used.
At today's BVVA annual meeting in Mainz, BVVA Chairwoman Gnekow stated that a technical system is being developed for this purpose. The blueprint is an existing supplementary agreement between the BVVA, the Federal Association of Patient-Specific Blistering Companies (BPAV) and the AOK . They hope that the issue can be resolved soon, Gnekow told PZ.
Also from German Pharmacists Association ( The DAV (German Association of Statutory Health Insurance Funds) stated that discussions were underway with the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds). Gnekow expressed his conviction that, if an extension of the transitional arrangement were necessary, this could be agreed upon bilaterally between the GKV-Spitzenverband and the DAV.
In her professional policy report, Gnekow outlined how (supply) pharmacies had experienced the past year, based on the four seasons. A year ago, she said, things were icy, when the industry was politically "at the beginning of winter." Then, in mid-June, came the "hard cold snap" when the draft bill for the Pharmacy Reform Act (ApoRG) came to light. That's when the down jackets came out, according to Gnekow. Communication was "pretty much frozen" at the time, Gnekow recalls the repeated media pushes by then-Federal Health Minister Karl Lauterbach (SPD).

pharmazeutische-zeitung